rs151173406
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_019109.5(ALG1):c.826C>T(p.Arg276Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,611,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R276Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_019109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG1 | NM_019109.5 | c.826C>T | p.Arg276Trp | missense_variant | 7/13 | ENST00000262374.10 | |
ALG1 | NM_001330504.2 | c.493C>T | p.Arg165Trp | missense_variant | 7/13 | ||
ALG1 | XM_017023457.3 | c.826C>T | p.Arg276Trp | missense_variant | 7/12 | ||
ALG1 | XR_007064892.1 | n.833C>T | non_coding_transcript_exon_variant | 7/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG1 | ENST00000262374.10 | c.826C>T | p.Arg276Trp | missense_variant | 7/13 | 1 | NM_019109.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248830Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135056
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459606Hom.: 0 Cov.: 41 AF XY: 0.00000689 AC XY: 5AN XY: 726172
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
ALG1-congenital disorder of glycosylation Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 17, 2023 | ClinVar contains an entry for this variant (Variation ID: 30539). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALG1 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. This missense change has been observed in individual(s) with congenital disorder of glycosylation (PMID: 20679665, 26931382; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 276 of the ALG1 protein (p.Arg276Trp). This variant is present in population databases (rs151173406, gnomAD 0.003%). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | May 07, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 12, 2023 | Variant summary: ALG1 c.826C>T (p.Arg276Trp) results in a non-conservative amino acid change located in the glycosyl transferase, family 1 domain (IPR001296) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 248830 control chromosomes (gnomAD). c.826C>T has been reported as a compound heterozygous genotype in the literature in multiple individuals affected with Congenital Disorder Of Glycosylation Type 1K, including at least one individual where it was confirmed to be in trans with a pathogenic variant and one case where it was reported as a de novo occurrence (e.g. Dupre_2010, Ng_2016, Fang_2021, Abu Bakar_2022). These data indicate that the variant is very likely to be associated with disease. A functional study examining the impact of the variant using an alg1-deficient yeast strain found that the variant was not able to rescue the growth-deficient phenotype to the same extent as the wild type protein (Ng_2016), however, as this assay is not quantitative it does not necessarily allow strong conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 35279850, 20679665, 34020146, 26931382). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | Sep 01, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). The variant is in trans with the other pathogenic variant. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.66; 3Cnet: 0.55). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000030539). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Congenital disorder of glycosylation Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 25, 2017 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2020 | The variant impaired the normal function of ALG1 (Ng et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 26931382, 20679665, 27670784) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at